Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(NY:
MAIA
)
3.740
-0.070 (-1.84%)
Official Closing Price
Updated: 8:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MAIA
< Previous
1
2
3
4
5
Next >
MAIA Biotechnology Announces No Exposure to Silicon Valley Bank
March 13, 2023
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Doses First Patients in Europe in Ongoing Phase 2 Trial (THIO-101) Evaluating THIO for Non-Small Cell Lung Cancer Treatment
March 07, 2023
From
MAIA Biotechnology, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
February 21, 2023
Via
Benzinga
ADDING MULTIMEDIA: MAIA Biotechnology’s Telomere-targeting Agent THIO, in Combination With Checkpoint Inhibitor Immune Therapies Atezolizumab (anti-PD-L1) or Pembrolizumab (anti-PD-1), Demonstrated Significantly Greater Tumor Inhibition
February 13, 2023
From
MAIA Biotechnology, Inc.
Via
Business Wire
Insiders Buying Adamas One And 1 Other Penny Stock
January 30, 2023
The Nasdaq recorded gains for the fourth week in a row. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...
Via
Benzinga
Sidoti's January Micro-Cap Conference
January 17, 2023
Via
ACCESSWIRE
MAIA Biotechnology Advances New Telomere-Targeting Molecule Program
January 17, 2023
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology to Participate in Four Upcoming Investor Conferences
January 05, 2023
From
MAIA Biotechnology, Inc.
Via
Business Wire
CalAmp And 2 Other Stocks Under $5 Insiders Are Aggressively Buying
December 30, 2022
The Dow Jones settled higher by over 300 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
MAIA Biotechnology Holds Successful Pre-IND Meeting with FDA for Planned US Expansion of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
December 20, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Expands Phase 2 THIO-101 Trial to Europe
December 13, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Establishment of Rule 10b5-1 Trading Plan
November 22, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Presents Preclinical Data at SITC Annual Meeting Validating Efficacy of THIO in Treating Hepatocellular Carcinoma
November 15, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 09, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
Sidoti's November Micro-Cap Virtual Conference
November 08, 2022
Via
ACCESSWIRE
MAIA Biotechnology to Participate in ThinkEquity Conference
October 06, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology to Present at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
September 29, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology to Participate in H.C. Wainwright 24th Annual Global Investment Conference
September 08, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology to Present Design of THIO-101 Trial at European Society for Medical Oncology (ESMO) Congress 2022
September 06, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology to Present Anticancer THIO Platform at XIV International Round Table on Nucleosides, Nucleotides, and Nucleic Acids
August 30, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 22, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
Opening Day: Hong Kong's GigaCloud Jumps In Nasdaq Debut
August 20, 2022
Shares of Hong Kong-based online marketplace provider GigaCloud jumped almost 30% in its debut earlier this week. It opened at $19.20 on Thursday, up 57% from its original price of $12.25 per share....
Via
Talk Markets
This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket
August 03, 2022
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday.
Via
Benzinga
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
August 04, 2022
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.
Via
Benzinga
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
August 03, 2022
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 03, 2022
It's time for another dive into the biggest pre-market stock movers as we check out the latest news investors need to know about Wednesday!
Via
InvestorPlace
MAIA Biotechnology Receives FDA Orphan Drug Designation for THIO for the Treatment of Small-Cell Lung Cancer (SCLC)
August 02, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Closing of Initial Public Offering
August 01, 2022
From
MAIA Biotechnology, Inc.
Via
Business Wire
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
August 03, 2022
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Via
Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
August 02, 2022
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.